Share Name Share Symbol Market Type Share ISIN Share Description
Anpario LSE:ANP London Ordinary Share GB00B3NWT178 ORD 23P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +2.50p +0.71% 355.00p 350.00p 360.00p 355.00p 352.50p 352.50p 6,040 08:24:42
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food Producers 24.3 2.7 12.8 27.8 81.27

Anpario Share Discussion Threads

Showing 1026 to 1049 of 1050 messages
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
DateSubjectAuthorDiscuss
19/7/2017
22:10
exactly but if I am right really a very modest carrot
srichardson8
19/7/2017
18:31
Thanks...... basically to try and keep them aboard then??
tailgunner2
19/7/2017
10:09
A grant of a right to the profit - if the two remain at the company for three years - of the difference between the set price of 342 and the price at which they can sell (when the shares are 'vested') in 2020. The shares are held in trust and have been bought with money loaned by the company i.e. 100k shares at 342 = 342k). So if they are sold at 442 they would each make £50k. A small carrot. Or so I understand.
srichardson8
18/7/2017
17:04
Can anyone explain what that RNS is all about in laymans terms?????
tailgunner2
02/7/2017
13:14
Thanks everyone for the AGM reviews. 👍
battlebus2
02/7/2017
12:19
I was at the AGM and agree with comments. But did come away with the feeling that the company has a bright future.
nocton
02/7/2017
11:35
Thanks, an excellent summary, and pretty much as I recall the meeting. I would only add the following comments The Chairman Came across as both thoroughly uninspired and uninspiring. Didn't for a minute make attendees feel as if he had put aside the morning if necessary for good interaction and discussion with shareholders, on the one occasion during the year when it is needed. His pre. AGM summary was useless, and he said very little about the current financial year when he was fully entitled to give more detail. The sooner he goes the better in my view. I see that after the meeting an RNS stated that he had sold his shares in the company!!?? The Board Lawrence came across as having some dynamism, but the CEO and FD seemed in danger of catching the complacent/laid back attitude of the Chairman. The company needs 2/3 capable, challenging and positive new non-execs. Let's hope we get them. Cash At Dec. 16 the cash balance was about £11 million, and no doubt higher now but the Chairman wouldn't confirm this for some reason. But it is arguable that they really should be putting it to better use than just sitting in the bank. The Future. Overall, the company seems to be doing okay. It is debt free, with a cash balance that represents approx. 15% of its market cap. which is a good position to be in in some ways, but there must presumably be much more potential if only somebody could put a rocket under the BOD.
truffle
29/6/2017
13:08
quite a few exceptionals in this year's accounts and more expected next year might temper enthusiasm though they say they are seeing strong sales growth some of which might be currency related and some due to the direct distribution model now being adopted,
mw8156
29/6/2017
07:11
AGM statement....strong sales growth... R Rose to step down.
battlebus2
09/5/2017
18:35
And back to new recent highs 👌
battlebus2
09/5/2017
18:07
Encouraging to see the Finance Director switching shares to an ISA account!
truffle
21/4/2017
10:49
Cerrito, thanks for extra ANP comments. Unfortunately I can't make ANP's AGM on June 29th which is being held at its brokers office in Central London. Listened again to Lord Lee's Shareradio podcast(many thanks to Jockthescot) where he outlined all the reasons why ANP should be a good long-term investment. However, I would like to get a feel for the new CEO, and also the long-term commitment of the chairman and Peter Lawrence both of whom have been on the board for over a decade. Would appreciate any reports after the AGM.
bottomfisher
20/4/2017
20:39
Thanks for that Bottomfisher Also note that on the website news of several overseas hires they have made-all appear to have impressive backgrounds- but as they do not date their news articles not sure when made. An increase in fixed costs and also requires a good investment of management time. Be interesting to discuss at AGM
cerrito
20/4/2017
14:37
Regarding earlier comments on the relative attractions of Anpario (ANP) versus ECO Animal Health Group (EAH) there is no question that EAH, which is roughly twice ANP’s size in terms of revenues, is the much faster growing business. According to Stockopedia, EAH’s revenues have been growing at a compound annual rate of 11.7% over the last five years - more than twice as fast as ANP. The same goes for EAH’s eps which have been growing at a compound annual rate of 26.3%. At current prices ANP is trading at around 20 times forecast earnings, according to Stockopedia, compared with EAH’s multiple of 32.6 times forecast earnings. On paper, at least, both shares seem over-valued at current prices. ANP’s shares may be being propped up by a hope that its pedestrian revenue growth will soon start to accelerate under a new CEO and a strategy of getting much closer to its customers in the field. But what if these plans do not fire up ANP’s revenue and profit growth? Interestingly, Peter Lawrence, the founder of EAH, its executive chairman and biggest shareholder, has been an ANP non-exec for more than a decade. Along with Richard Rose, ANP’s chairman, he is the only non-exec on ANP’s board. He is better placed than anyone to know what ANP is really worth. ANP and EAH are relatively small global players serving similar markets. ANP provides natural food additives to the live stock industry and EAH provides pharmaceutical products for global animal health markets. Perhaps EAH could emerge as a suitor for ANP if its revenue and profit growth fails to take off.
bottomfisher
18/4/2017
16:48
Bit severe that chopping of s.p.....??
tailgunner2
17/4/2017
10:10
Why are we talking down ANP, the price has been going up so all shareholders should be happy. If you think it's overvalued bank a few profits. I can't understand when there's such dross around the markets.
battlebus2
17/4/2017
09:57
Cerrito, you just may be right about ANP being too small, at 70m, to attract a really major company, but EAH is a 320m company and growing quickly, so I can't think it would apply there.
aimingupward2
16/4/2017
23:26
Thanks aimingupward2 I am not in EAH at the moment and never have been and I was wondering if they used distributors and I note your comments that they do. My understanding of why ANP is moving from distributors to their own people is not the margin/cost avoidance per se but rather to increase sales and getting a better understanding of what drives demand for their product by having close contact with the end user. Be interesting to chat with the CEO at the AGM on this. I take your point about a large company taking over EAH to use its own distribution network; the same comment applies for ANP, especially for getting buy in with the big US producers. When ANP's price was in the 240p area I was half expecting a takeover..perhaps big companies find ANP too small...and indeed EAH.
cerrito
16/4/2017
22:28
EAH has been and is increasing t/o, profit and eps rapidly and can be expected to continue to do so following recentl regulatory approvals and others in the pipeline and expected fairly soon. Increasing dividend payments too. It has very high barriers to entry for any would-be competitors. Currently it largely uses distributors to achieve sales, which is costly. EBITDA would be much higher in the hands of a big company with it's own distribution network already in place, so takeover is possible - or the company will develop it's own sales forces around the world and increase margins. P.E. more like 25 or less for the year just started. Anyway, enough said. If it doesn't appeal, based on past cash flow, it doesn't.
aimingupward2
16/4/2017
21:51
Although ANP earnings have trodden water, op cashflow per share, perhaps a better measure have continued to increase. .......adj EPS....OP C/F PS 2012...15.1p......11.5p 2013...13.1p......14.9p 2014...14.8p......16.1p 2015...16.0p......16.7p 2016...18.3p......18.5p Free cashflow per share has been flat due to increasing capex. (Source stockopedia) There are unfortunately no predictions for 17/18. EAH is on a PER of 37 this year and has had negative free cashflow for the last 2 years, so don't see why that is better value. All the best, ottrott
ottrott
16/4/2017
15:58
Glasshalfull, I've never been in this one, though I have looked into it as the sector is interesting. I fully agree with your conclusions and feel that Eco Animal Health, (EAH), offers far better prospects. It's share price has flatlined for around 6 months and is due a rise ahead of, and through, what will undoubtedly be excellent results for the year recently ended. Take a look if you're not already familiar with it.
aimingupward2
16/4/2017
15:49
Very comprehensive GHF. One of the first prerequisites for me to buyin to a new company is a growing EPS so despite the many appealing qualities of #ANP I won't be buying in at this point. GLA
martinthebrave
16/4/2017
13:29
ANP Share price still defies gravity despite earnings downgrades. I saw martinthebrave's post looking for clarity on earnings for the coming year and revisited my detailed post on earnings in March 2016 (post 910) where I talked of earnings stalling & intimated that I felt the share price was up with events at c.250p at the time. Shares are (+67p) since my post...so what do I know!!!??? The share price was 134p in March 2013 when they released 2012 figures, and had risen to 305p when they released 2016 results on the 8th March 2017, or rise of 128% in 4-years. This is during a period when earnings have only risen marginally and are forecast to tread water this year & next. Worth clarifying that I still believe Anpario is a quality company & hope to reinvest at some point. Just don't feel I should be paying up in anticipation of growth 18 months away, especially when earnings have been fairly static for the last 4 years which I describe below. Looking back to post 910 a year ago, Peel Hunt lowered 2017 estimates from £5.3m PBT to £4.6m which translated into the forecasts for adj EPS falling from 20.7p to 18.1p. PH indicated that this would result in ANP achieving 12% earnings growth in 2017. In a March 2017 PH lowered 2017 estimates yet again, this time from the £4.6m to £4.3m or 17.7p adj EPS to 16.9p. So we now have a (-4%) earnings contraction in 2017. Singers has an even lower forecast of 14.7p adj EPS for 2017 My point is that ANP has essentially treaded water - in terms of earnings - for a number of years now whatever way one cares to look at it, with forecasts suggesting that earnings will continue in a similar vein for the next 18 months. Anpario Adj EPS: - 2012 - 15.1p EPS 2013 - 13.1p EPS 2014 - 14.8p EPS 2015 - 16p EPS 2016 - 16.6p EPS Consensus forecasts: - 2017 - 15.8P EPS 2018 - 15.4p EPS Worth pointing out that cash has risen from £3.7m at year end 2012 to £11.1m at end of 2016, but the dividend has only risen a meagre 2.5p (from 3p to 5.5p) in 4 years. So in conclusion, I recognise the steps management are taking to invest in subsidiaries & build relationships that will hopefully drives sales & earnings in the future. However, as I've discussed above, I happen to believe that the current 317p share price & PER of over 20 is simply too high. If ANP was churning out consistent 10%-15% earnings growth YoY then I would agree with the current rating, but in 2016 they produced marginal earnings growth with a dividend yield of only 1.7% despite strong cash generation. Earnings are forecast to fall back this year and next, so paying up 18/24 months in advance for growth doesn't appeal to me. Hopefully I'll join shareholders again as growing earnings materialise, or in circumstances where I consider that the share price has fallen back to a reasonable rating. Only my tuppenceworth FWIW. Best wishes to holders. Kind regards, GHF
glasshalfull
14/4/2017
10:38
srichardson.8 Much appreciated. It is the one think that puts me off buying in. I will take another look.
martinthebrave
Chat Pages: 42  41  40  39  38  37  36  35  34  33  32  31  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20170720 18:49:06